Kawamatawong Theerasuk, Onnipa Jitsupa, Suwatanapongched Thitiporn
Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Diagnostic and Therapeutic Radiology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Int J Chron Obstruct Pulmon Dis. 2018 Mar 2;13:761-769. doi: 10.2147/COPD.S139776. eCollection 2018.
The prevalence rate of bronchiectasis in COPD is variable. Coexisting bronchiectasis and COPD may influence COPD severity and exacerbation.
We investigated whether bronchiectasis is associated with frequent or severe COPD exacerbation. Lower airway bacterial and mycobacterial infections are a possible mechanism for bronchiectasis.
A cross-sectional study was conducted in 2013-2014. COPD exacerbations and hospitalizations were reviewed. Spirometry and CT were performed. COPD symptoms were assessed by using the COPD assessment test (CAT) and modified Medical Research Council (mMRC) dyspnea scale. Sputum inductions were performed and specimens were sent for microbiology.
We recruited 72 patients. Global Initiative for Chronic Obstructive Lung Disease (GOLD) A, B, C, and D, were noted in 20%, 27.1%, 14.3%, and 38.6% of the patients, respectively. Frequent exacerbations (≥2) and/or ≥1 hospitalization in the previous year were observed in 40.3% of patients. Median mMRC of COPD with frequent and non-frequent exacerbations was 1.0 (range 1-2) and 2.0 (range 1-3), (=0.002), respectively. Median CAT of COPD with frequent and non-frequent exacerbations was 20.5 (3-37) and 11.0 (2-32), (=0.004), respectively. CT-detected bronchiectasis was observed in 47.2% of patients. Median mMRC of COPD with and without bronchiectasis was 1.0 (0-4) and 1.0 (0-4) (=0.22), respectively. Median CAT of COPD with and without bronchiectasis was 16.2 (95% CI: 12.9-19.6) and 13.0 (3-37), (=0.49), respectively. The lower post-bronchodilator forced expiratory volume in 1 second (FEV) of COPD with frequent exacerbations than those without was noted (=0.007). The post-bronchodilator forced expiratory volume at 1 second percent in patients with and without bronchiectasis was not different (=0.91). After adjusting for gender, severity of airflow obstruction, severity of COPD symptoms, the odds ratio for bronchiectasis with frequent and/or severe exacerbation was 4.99 (95% CI: 1.31-18.94), (=0.018). Neither bacterial nor mycobacterial airway infection was associated with bronchiectasis or frequent exacerbation.
Bronchiectasis is common in Thai COPD. It was associated with frequent exacerbation or hospitalization. Mycobacterial tuberculosis in COPD patients with bronchiectasis was uncommon.
慢性阻塞性肺疾病(COPD)中支气管扩张的患病率各不相同。支气管扩张与COPD并存可能会影响COPD的严重程度和急性加重情况。
我们调查了支气管扩张是否与COPD频繁或严重急性加重相关。下呼吸道细菌和分枝杆菌感染是支气管扩张的一种可能机制。
在2013年至2014年进行了一项横断面研究。回顾了COPD急性加重和住院情况。进行了肺功能测定和CT检查。使用COPD评估测试(CAT)和改良的医学研究委员会(mMRC)呼吸困难量表评估COPD症状。进行痰液诱导并将标本送去做微生物学检查。
我们招募了72名患者。全球慢性阻塞性肺疾病倡议(GOLD)A、B、C和D级分别在20%、27.1%、14.3%和38.6%的患者中出现。40.3%的患者在前一年观察到频繁急性加重(≥2次)和/或≥1次住院。频繁急性加重和非频繁急性加重的COPD患者的mMRC中位数分别为1.0(范围1 - 2)和2.0(范围1 - 3),(P = 0.002)。频繁急性加重和非频繁急性加重的COPD患者的CAT中位数分别为20.5(3 - 37)和11.0(2 - 32),(P = 0.004)。47.2%的患者通过CT检测到支气管扩张。有和无支气管扩张的COPD患者的mMRC中位数分别为1.0(0 - 4)和1.0(0 - 4)(P = 0.22)。有和无支气管扩张的COPD患者的CAT中位数分别为16.2(95%CI:12.9 - 19.6)和13.0(3 - 37),(P = 0.49)。频繁急性加重的COPD患者支气管扩张后1秒用力呼气容积(FEV)低于无频繁急性加重的患者(P = 0.007)。有和无支气管扩张患者的支气管扩张后1秒用力呼气容积百分比无差异(P = 0.91)。在调整性别、气流阻塞严重程度、COPD症状严重程度后,支气管扩张伴频繁和/或严重急性加重的比值比为4.99(95%CI:1.31 - 18.94),(P = 0.018)。细菌和分枝杆菌气道感染均与支气管扩张或频繁急性加重无关。
支气管扩张在泰国COPD患者中很常见。它与频繁急性加重或住院相关。COPD合并支气管扩张患者中的肺结核并不常见。